This announcement is a separate document:
盘龙药业：关于控股股东、实际控制人持股比例被动稀释超过1%的公告
Panlong Pharmaceutical: Announcement on passively diluting the shareholding ratio of controlling shareholders and actual controllers by more than 1%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.